ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

S100A8 as a Promising Biomarker and Oncogenic Immune Protein in the Tumor Microenvironment: An Integrative Pancancer Analysis

Wu, Zixuan; Jiang, Dongli; Huang, Xuyan; Cai, Minjie; Yuan, Kai; Huang, Peidong*广州中医药大学; 南方医科大学; 云南大学; 5
Journal of Oncology2022-3-18DOI: 10.1155/2022/6947652
5被引5阅读
引用收藏
分享

摘要

Background. S100 Calcium Binding Protein A8 (S100A8) is beneficial for cancer immunotherapy. However, the processes underlying its therapeutic potential have not been completely studied. Methods. The Cancer Genome Atlas provides raw data on 33 different cancer types. GEO made available GSE67501, GSE78220, and IMvigor210. We investigated S100A8's genetic changes, expression patterns, and survival studies. The linkages between S100A8 and TME, as well as its association with immunological processes/elements and the major histocompatibility complex, were explored to effectively understand the role of S100A8 in cancer immunotherapy. Three distinct immunotherapeutic cohorts were employed to examine the relationship between S100A8 and immunotherapeutic response. Results. S100A8 expression was high in tumor tissue. The overexpression of S100A8 is associated with poor clinical outcome in patients with overall survival. S100A8 is associated with immune cell infiltration, immunological modulators, and immunotherapeutic indicators. S100A8 overexpression is connected to immune-related pathways. However, no statistically significant connection between S100A8 and immunotherapeutic response was identified. Conclusions. S100A8 may be a reliable biomarker for tumor prognosis and a viable prospective therapeutic target for human cancer immunotherapy (e.g., GBM, KIRC, LGG, and LIHC).

学科与关键词

关键词
CELLSINFLAMMATIONEXPRESSIONCOMPLEX
相关
加载中…
  • Proinflammatory S100A8 Induces PD-L1 Expression in Macrophages, Mediating Tumor Immune Escape.
    Li, Zhengshuo; Wang, Jing; Zhang, Xuemei; Liu, Peishan; Zhang, Xiaoyue; Wang, Jia; Zheng, Xiang; Wei, Lingyu; Peng, Qiu; Liu, Can; Yan, Qun; Shen, Shourong; Li, Xiayu; Ma, Jian*Journal of Immunology, 2020, 204(9): 2589-2599.
  • In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis
    Wu, Zixuan; Jiang, Yanhui; Huang, Xuyan; Cai, Minjie; Yuan, Kai*; Huang, Peidong*; Wang, ZuhongEvidence-based Complementary and Alternative Medicine, 2022, 2022: 7730433.
  • Overexpression of TREM1 is Associated with the Immune-Suppressive Microenvironment and Unfavorable Prognosis in Pan-Cancer
    Zhou, Xinwei; Lin, Ke; Fu, Liangmin; Liu, Fei; Lin, Hansen; Chen, Yuhang; Zhuang, Bowen; Liang, Hui; Deng, Qiong; Wang, Zhu; Chen, Wei; Luo, Junhang; Cao, Jiazheng*; Li, Pengju*Journal of Inflammation Research, 2023, 16: 1375-1391.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Oncology
发表日期
2022-03-18
卷期
第 2022 卷
页码
6947652
DOI
10.1155/2022/6947652
期刊等级
4区
成果收录
SCIE
资助标注
Health and Health Commission of Yunnan Province 2020 High-level TCM Reserve Talents Incubation Project (Yunwei TCM Development [2021]) [1]; Second Round of Construction Project of The National Traditional Chinese Medicine School Heritage Studio of the State Administration of Traditional Chinese Medicine [[2019] 62]; Joint Special Project of Yunnan Provincial Department of Science and Technology-Yunnan University of Traditional Chinese Medicine on Applied Basic Research [2017FF116(-028)]; Yunnan Provincial Department of Education [2014Y238]

作者

  • W

    Wu, Zixuan (第一作者)

    guangzhou univ chinese med

  • J

    Jiang, Dongli

    5 · southern med univ

查看全部 6 位作者收起作者
  • H

    Huang, Xuyan

    guangzhou univ chinese med

  • C

    Cai, Minjie

  • Y

    Yuan, Kai

    yunnan univ

  • H

    Huang, Peidong (通讯)

    yunnan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417